People who suffer from peripheral neuropathy and diabetic neuropathy describe their symptoms in many different ways. Some of the more commonly descriptions include pain, burning, “pins and needles” sensations, electric shocks, tightness of the skin and the sensation of walking on cardboard or sandpaper. Many of the prescription medications used for the treatment of neuropathy such as Neurontin or Lyrica, are not always successful in reducing the discomfort of neuropathy. In fact studies show that these medications are effective less than 50% of the cases. In addition Neurontin and Lyrica have many associated side effects. More common side-effects include extreme fatigue and sleepiness, loss of concentration and weight gain. Newer, more effective treatments must be developed for relieving neuropathy discomfort.
Botox which is the most common administered cosmetic treatment in the world is now under study for treating peripheral neuropathy. Botox (known as botilinum toxin type A), is actually a toxin that selectively paralyzes or relaxes certain muscle groups in the body. Clinical studies conducted around the world have been encouraging as an effective means in reducing neuropathy pain and discomfort. A recent clinical study at the New York University School of Medicine suggests that Botox can provide pain relief for several types of neuropathy including diabetic neuropathy. Similar studies were conducted in France and Canada with similar conclusions: Botox can help reduce chronic neuropathy pain.
The Foot Pain Center is studying the effects of Botox in relieving neuropathic pain. Allergan, a multi-specialty health care company, based in Irvine California, a manufacturer of Botox, has been extremely helpful in providing literature and case reports for the study.